Related Experiment Videos

The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ

T A Waldmann1

  • 1Metabolism Branch, National Cancer Institute, Bethesda, MD 20892.

JAMA
|January 12, 1990
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos